Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma

NCT01022918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Naive Unresectable Glioblastoma

Interventions

DRUG: Avastin + Campto / radiotherapy + Temodal + Avastin (4 cures)
DRUG: Temodal/radiotherapy

Sponsor

Centre Georges Francois Leclerc

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]